Results 201 to 210 of about 9,142,402 (345)

Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies

open access: yesClinical Chemistry and Laboratory Medicine, 2018
John S. Calise   +16 more
semanticscholar   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Development of a Tandem Mass Spectral Library for the Detection of Triterpenoids in Plant Metabolome Based on Reference Standards. [PDF]

open access: yesPlants (Basel)
Zareena B   +10 more
europepmc   +1 more source

RefSeq Functional Elements as experimentally assayed nongenic reference standards and functional interactions in human and mouse. [PDF]

open access: yesGenome Res, 2022
Farrell CM   +11 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Evaluation of Each Three <i>Entamoeba histolytica</i>- and <i>Strongyloides stercoralis</i>-Specific Real-Time PCR Assays Applying Test Comparisons Without Reference Standards. [PDF]

open access: yesMicroorganisms
Zautner AE   +13 more
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy